Lycia Therapeutics Files for IPO
Dow Jones2026/10/05 20:59By Josh Beckerman Lycia Therapeutics, which is developing drugs to degrade disease-causing extracellular proteins, filed for an initial public offering Monday. The South San Francisco, Calif., company has an initial focus on addressing autoimmune, inflammatory and allergic diseases. Lycia is seeking a Nasdaq Global Market listing under the symbol LYCA. In June, the company reported a $75 million Series D financing co-led by Janus Henderson Investors and Balyasny Asset Management. In 2020, Lycia exited stealth mode with a $50 million commitment from founding investor Versant Ventures. Jefferies, TD Cowen, Evercore ISI and Guggenheim Securities are joint book-running managers. Write to Josh Beckerman at josh.beckerman@wsj.com (END) Dow Jones Newswires October 05, 2026 16:59 ET (20:59 GMT)
By Josh Beckerman
Lycia Therapeutics, which is developing drugs to degrade disease-causing extracellular proteins, filed for an initial public offering Monday.
The South San Francisco, Calif., company has an initial focus on addressing autoimmune, inflammatory and allergic diseases.
Lycia is seeking a Nasdaq Global Market listing under the symbol LYCA.
In June, the company reported a $75 million Series D financing co-led by Janus Henderson Investors and Balyasny Asset Management. In 2020, Lycia exited stealth mode with a $50 million commitment from founding investor Versant Ventures.
Jefferies, TD Cowen, Evercore ISI and Guggenheim Securities are joint book-running managers.
Write to Josh Beckerman at josh.beckerman@wsj.com
(END) Dow Jones Newswires
October 05, 2026 16:59 ET (20:59 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Eurozone Sentix Investor Confidence Index slips to 2.4 in November from 2.7 in October
SoftBank develops contingency plans for slowdown in US data center business, considers shifting to other countries
A new twist has emerged in the US AI data center investment boom. SoftBank is preparing for cooling US demand and a deteriorating political environment, and does not rule out shifting data center construction priorities to other countries. As cross-border computing power delivery capability improves and investment returns come under question, the logic behind AI infrastructure expansion is loosening, and over $3.5 trillion in infrastructure investment now faces potential impairment risks.
Quantumrail Cancels 10 Billion Won Convertible Bond Offering
Crypto prices
More
